Compare ALG & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALG | SRPT |
|---|---|---|
| Founded | 1955 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 1996 | 2000 |
| Metric | ALG | SRPT |
|---|---|---|
| Price | $171.67 | $17.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 28 |
| Target Price | ★ $225.00 | $25.24 |
| AVG Volume (30 Days) | 142.4K | ★ 2.2M |
| Earning Date | 03-02-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.85% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 8.59 | N/A |
| Revenue | $1,603,715,000.00 | ★ $2,198,237,000.00 |
| Revenue This Year | $5.51 | N/A |
| Revenue Next Year | $3.96 | N/A |
| P/E Ratio | $18.63 | ★ N/A |
| Revenue Growth | N/A | ★ 15.58 |
| 52 Week Low | $156.30 | $10.42 |
| 52 Week High | $233.29 | $76.33 |
| Indicator | ALG | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 50.96 |
| Support Level | $168.24 | $17.05 |
| Resistance Level | $181.61 | $19.55 |
| Average True Range (ATR) | 5.93 | 0.85 |
| MACD | -0.57 | 0.20 |
| Stochastic Oscillator | 68.46 | 83.88 |
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial, and agricultural use. Its products include agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck-mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, snow removal equipment, etc. The company's reportable segments are Vegetation Management, which generates the maximum revenue, and Industrial Equipment. Geographically, the company generates maximum revenue from the United States, followed by Canada, France, the UK, Brazil, the Netherlands, and other regions.
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.